BSE filing, NSE: RSYSTEMS. Summary written from the filing by ALFA Finder's alert engine.
R Systems International Ltd: key numbers
- Share price
- ₹252.20
- Market cap
- ₹2,988 Cr
- Revenue (annual)
- ₹1,958 Cr
- Net profit (annual)
- ₹186.2 Cr
- P/E (TTM)
- 15.5×Sector 22.9×
- Promoter holding
- 51.84%-0.01% QoQ
- FII holding
- 3.92%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from R Systems International Ltd
All →R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
R Systems International Management Change
R Systems appointed Vikas Basra as Senior Management Personnel, Chief AI Officer, effective 26 October 2026. He brings over 24 years of technology and AI leadership experience.
- Execution
- Full time employment, effective from 26 October 2026
R Systems International Other Announcement
R Systems International Ltd has submitted its quarterly shareholding pattern for the quarter ended September 30, 2026, as required under SEBI regulations.
R Systems International Credit Rating
ICRA Limited has reaffirmed the issuer rating of R Systems International Limited as [ICRA]AA-(Stable).
R Systems International Debt & Borrowing: ₹6.76 Cr
R Systems International Limited has completed a quarterly interest payment of ₹6.76 Crore. The payment pertains to its 9.75% unsecured non-convertible debentures.
- Value
- ₹6.76 Cr
R Systems International Management Change
R Systems International Limited has appointed Mr. Gurprit Singh as the Company Secretary and Compliance Officer, effective September 25, 2026.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.